120 related articles for article (PubMed ID: 7789467)
1. Monitoring of endotoxin, interleukin-6 and C-reactive protein serum concentrations in neutropenic patients with fever.
Engervall P; Granström M; Andersson B; Björkholm M
Eur J Haematol; 1995 Apr; 54(4):226-34. PubMed ID: 7789467
[TBL] [Abstract][Full Text] [Related]
2. An analysis of interleukin-8, interleukin-6 and C-reactive protein serum concentrations to predict fever, gram-negative bacteremia and complicated infection in neutropenic cancer patients.
Engel A; Mack E; Kern P; Kern WV
Infection; 1998; 26(4):213-21. PubMed ID: 9717678
[TBL] [Abstract][Full Text] [Related]
3. Endotoxin, interleukin-6 and phospholipase-A2 as markers of sepsis in patients with hematological malignancies.
Rintala E; Pulkki K; Mertsola J; Nevalainen T; Nikoskelainen J
Scand J Infect Dis; 1995; 27(1):39-43. PubMed ID: 7784812
[TBL] [Abstract][Full Text] [Related]
4. Endotoxaemia and inflammatory mediators in febrile patients with haematological disease.
Günther G; Gårdlund B; Hast R; Kimby E; Nordin M; Wretlind B
J Intern Med; 1995 Jan; 237(1):27-33. PubMed ID: 7830027
[TBL] [Abstract][Full Text] [Related]
5. Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein.
von Lilienfeld-Toal M; Dietrich MP; Glasmacher A; Lehmann L; Breig P; Hahn C; Schmidt-Wolf IG; Marklein G; Schroeder S; Stuber F
Eur J Clin Microbiol Infect Dis; 2004 Jul; 23(7):539-44. PubMed ID: 15221617
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of serum cytokine patterns during start of fever in patients with neutropenia.
Engervall P; Andersson B; Björkholm M
Br J Haematol; 1995 Dec; 91(4):838-45. PubMed ID: 8547127
[TBL] [Abstract][Full Text] [Related]
7. Plasma endotoxin and cytokine levels in neutropenic and non-neutropenic bacteremic patients.
Hynninen M; Valtonen M; Vaara M; Markkanen H; Kuusela P; Saxen H; Takkunen O
Eur J Clin Microbiol Infect Dis; 1995 Dec; 14(12):1039-45. PubMed ID: 8681977
[TBL] [Abstract][Full Text] [Related]
8. The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies.
El-Maghraby SM; Moneer MM; Ismail MM; Shalaby LM; El-Mahallawy HA
J Pediatr Hematol Oncol; 2007 Mar; 29(3):131-6. PubMed ID: 17356388
[TBL] [Abstract][Full Text] [Related]
9. Cytokine concentrations are not predictive of bacteremia in febrile neutropenic patients.
Buyukberber N; Buyukberber S; Sevinc A; Camci C
Med Oncol; 2009; 26(1):55-61. PubMed ID: 18686048
[TBL] [Abstract][Full Text] [Related]
10. TNF alpha, IL-1 beta and IL-6 plasma levels in neutropenic patients after onset of fever and correlation with the C-reactive protein (CRP) kinetic values.
Herrmann JL; Blanchard H; Brunengo P; Lagrange PH
Infection; 1994; 22(5):309-15. PubMed ID: 7531179
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6, interleukin-8, interleukin-10, and C-reactive protein in febrile neutropenia in children with malignant diseases.
Spasova MI; Terzieva DD; Tzvetkova TZ; Stoyanova AA; Mumdzhiev IN; Yanev IB; Genev ED
Folia Med (Plovdiv); 2005; 47(3-4):46-52. PubMed ID: 16761394
[TBL] [Abstract][Full Text] [Related]
12. Plasma IL-8 and IL-6 levels can be used to define a group with low risk of septicaemia among cancer patients with fever and neutropenia.
de Bont ES; Vellenga E; Swaanenburg JC; Fidler V; Visser-van Brummen PJ; Kamps WA
Br J Haematol; 1999 Nov; 107(2):375-80. PubMed ID: 10583227
[TBL] [Abstract][Full Text] [Related]
13. Assessment of systemic inflammation markers to differentiate a stable from a deteriorating clinical course in patients with febrile neutropenia.
Persson L; Söderquist B; Engervall P; Vikerfors T; Hansson LO; Tidefelt U
Eur J Haematol; 2005 Apr; 74(4):297-303. PubMed ID: 15777341
[TBL] [Abstract][Full Text] [Related]
14. Assessment of measuring circulating levels of interleukin-6, interleukin-8, C-reactive protein, soluble Fc gamma receptor type III, and mannose-binding protein in febrile children with cancer and neutropenia.
Lehrnbecher T; Venzon D; de Haas M; Chanock SJ; Kühl J
Clin Infect Dis; 1999 Aug; 29(2):414-9. PubMed ID: 10476751
[TBL] [Abstract][Full Text] [Related]
15. Lipopolysaccharide-binding protein: a possible diagnostic marker for Gram-negative bacteremia in neutropenic cancer patients.
Oude Nijhuis CSM; Vellenga E; Daenen SMGJ; van der Graaf WTA; Gietema JA; Groen HJM; Kamps WA; de Bont ESJM
Intensive Care Med; 2003 Dec; 29(12):2157-2161. PubMed ID: 14569424
[TBL] [Abstract][Full Text] [Related]
16. Endogenous haemopoietic growth factors in neutropenia and infection.
Cebon J; Layton JE; Maher D; Morstyn G
Br J Haematol; 1994 Feb; 86(2):265-74. PubMed ID: 7515265
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 and its relationship to C-reactive protein and fever in children with febrile neutropenia.
Heney D; Lewis IJ; Evans SW; Banks R; Bailey CC; Whicher JT
J Infect Dis; 1992 May; 165(5):886-90. PubMed ID: 1569338
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of procalcitonin, neopterin, C-reactive protein, IL-6 and IL-8 as a diagnostic marker of infection in patients with febrile neutropenia.
Prat C; Sancho JM; Dominguez J; Xicoy B; Gimenez M; Ferra C; Blanco S; Lacoma A; Ribera JM; Ausina V
Leuk Lymphoma; 2008 Sep; 49(9):1752-61. PubMed ID: 18661397
[TBL] [Abstract][Full Text] [Related]
19. Clinical value of serial measurement of serum C-reactive protein level in neutropenic patients.
Yonemori K; Kanda Y; Yamamoto R; Hamaki T; Suguro M; Chizuka A; Matsuyama T; Takezako N; Miwa A; Togawa A
Leuk Lymphoma; 2001 May; 41(5-6):607-14. PubMed ID: 11378578
[TBL] [Abstract][Full Text] [Related]
20. Risk index score for bacteremia in febrile neutropenic episodes in children with malignancies.
Spasova MI; Grudeva-Popova JG; Kostyanev SS; Genev ED; Stoyanova AA; Kirina VI; Moumdjiev IN
J BUON; 2009; 14(3):411-8. PubMed ID: 19810131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]